SURI holdings

All 39 positions of Simplify Propel Opportunities ETF.

Download CSV

Positions

Top 10 weight

155.1%

Effective holdings

4.0

1 / sum of squared weights

In stocks

97.8%

In bonds

77.9%

Outside the US

10.6%

Asset mix

Equity97.8%
Treasury76.8%
Corporate Bond1.2%
Cash-75.2%

Sectors

95% of stocks classified

Health Care51.6%
Energy40.0%
Technology0.8%
Industrials0.0%

Countries

United States165.1%
Canada7.0%
United Kingdom2.1%
France1.5%

Bond holdings

Weighted average maturity: 0.3 years
Weighted average coupon: 0.08%
Maturing in 0-1y: 77.9%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT2026-10	Treasury	76.77%	$59M	60,000,000	US
2	PAGPPlains GP Holdings, L.P. Class A Units representing Limited Partner Interests	Equity	39.97%	$31M	1,272,360	US
3	ACHVAchieve Life Sciences, Inc.	Equity	12.11%	$9.4M	1,432,105	US
4	MISTMilestone Pharmaceuticals Inc. Common Shares	Equity	5.81%	$4.5M	3,349,379	CA
5	ACHIEVE LIFE SCIENCES INC	Equity	4.42%	$3.4M	966,667	US
6	DCTHDelcath Systems Inc	Equity	4.26%	$3.3M	261,126	US
7	PHATPhathom Pharmaceuticals, Inc. Common Stock	Equity	3.50%	$2.7M	249,267	US
8	CORTCorcept Therapeutics Inc.	Equity	2.98%	$2.3M	26,434	US
9	ABEOAbeona Therapeutics Inc. Common Stock	Equity	2.76%	$2.1M	345,416	US
10	CLDXCelldex Therapeutics, Inc	Equity	2.56%	$2.0M	53,134	US
11	KYTXKyverna Therapeutics, Inc. Common Stock	Equity	2.11%	$1.6M	182,603	US
12	CMPSCOMPASS Pathways Plc American Depository Shares	Equity	2.09%	$1.6M	114,281	GB
13	LONALeonaBio, Inc. Common Stock	Equity	1.78%	$1.4M	149,279	US
14	IVAInventiva S.A. American Depository Shares	Equity	1.53%	$1.2M	313,483	FR
15	AQSTAquestive Therapeutics, Inc. Common Stock	Equity	1.50%	$1.2M	278,723	US
16	ARTVArtiva Biotherapeutics, Inc. Common Stock	Equity	1.27%	$983K	101,355	US
17	ZVRAZevra Therapeutics, Inc. Common Stock	Equity	1.25%	$966K	67,372	US
18	OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares	Equity	1.23%	$947K	219,387	US
19	PALIPalisade Bio, Inc. Common Stock	Equity	1.22%	$942K	450,543	US
20	TELESAT CANADA / TELESAT LLC2026-12	Corporate Bond	1.16%	$895K	1,000,000	CA
21	OCULOcular Therapeutix, Inc.	Equity	1.03%	$796K	81,051	US
22	ACHIEVE LIFE SCIEN RTS	Equity	0.97%	$748K	247,593	US
23	EYPTEyePoint, Inc. Common Stock	Equity	0.84%	$649K	45,409	US
24	IMUXImmunic, Inc. Common Stock	Equity	0.61%	$472K	30,725	US
25	UPBUpstream Bio, Inc. Common Stock	Equity	0.56%	$430K	62,113	US
26	AKROAkero Therapeutics, Inc. Common Stock	Equity	0.55%	$427K	145,609	US
27	SABSSAB Biotherapeutics, Inc. Common Stock	Equity	0.53%	$409K	104,849	US
28	OVIDOvid Therapeutics Inc. Common Stock	Equity	0.34%	$260K	96,817	US
29	ALTIMMUNE INC	Equity	0.00%	$3K	79,075	US
30	CVRChicago Rivet & Machine Co.	Equity	0.00%	$2K	25,000	US
31	Eiger BioPharmaceuticals Inc	Equity	0.00%	$900	90,000	US
32	MILESTONE PHARMACE WTS	Equity	0.00%	$2	1,842,974	US
33	JASPER THERAPEUTIC WTS	Equity	0.00%	$1	609,053	US
34	WTS - TENAYA THERAPEUTICS	Equity	0.00%	$1	560,000	US
35	QUOIN PHARMACEUTIC WTS	Equity	0.00%	$0	34,895	US
36	QUOIN PHARMACEUTIC WTS	Equity	0.00%	$0	34,895	US
37	QUOIN PHARMACEUTIC WTS	Equity	0.00%	$0	34,895	US
38	QUOIN PHARMACEUTIC WTS	Equity	0.00%	$0	34,895	US
39	MORGAN STANLEY & CO. LLC	Cash	-75.22%	−$58M	-58,112,171	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	ACHVACHIEVE LIFE SCIENCES INC	5.02%	12.11%	+20.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MISTMILESTONE PHARMACEUTICALS INC	2.58%	5.81%	+122.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	Oculis Holding AG	2.56%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	VRDNViridian Therapeutics Inc	1.59%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	VORVOR BIOPHARMA INC	1.38%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	TRVITrevi Therapeutics Inc	1.13%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ARTVARTIVA BIOTHERAPEUTICS INC	0.22%	1.27%	+336.3%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ACHIEVE LIFE SCIEN RTS	—	0.97%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	FDMT4D Molecular Therapeutics Inc	0.95%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	CMPSCOMPASS PATHWAYS PLC	1.27%	2.09%	−28.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	Zealand Pharma As	0.82%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	CORTCORCEPT THERAPEUTICS INC	2.19%	2.98%	−30.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	KLRSKALARIS THERAPEUTICS INC	0.73%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CHRSCoherus Oncology Inc.	0.62%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	CLDXCELLDEX THERAPEUTICS INC	3.16%	2.56%	−23.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	SABSSAB BIOTHERAPEUTICS INC	1.03%	0.53%	−44.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ABEOABEONA THERAPEUTICS INC	3.23%	2.76%	−31.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	UPBUPSTREAM BIO INC	1.01%	0.56%	−20.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CRVSCorvus Pharmaceuticals Inc	0.43%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PALIPALISADE BIO INC	0.88%	1.22%	+28.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	IVAINVENTIVA SA	1.82%	1.53%	+37.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CONNECT BIOPHARMA HOLDINGS LTD	0.20%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	EYPTEYEPOINT INC	0.99%	0.84%	−15.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AQSTAQUESTIVE THERAPEUTICS INC	1.40%	1.50%	+19.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	IMUXIMMUNIC INC	0.70%	0.61%	−30.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	OVIDOVID THERAPEUTICS INC	0.42%	0.34%	−26.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ZVRAZEVRA THERAPEUTICS INC	1.29%	1.25%	−30.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	PHATPhathom Pharmaceuticals Inc	7.10%	4.20%	−18.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	VRDNViridian Therapeutics Inc	4.28%	1.59%	−45.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	WTS - ACHIEVE LIFE SCI	2.53%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	CORTCorcept Therapeutics Inc.	—	2.19%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	NKTRNektar Therapeutics	1.57%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	AQSTAquestive Therapeutics Inc	—	1.40%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	CMPSCompass Pathways plc	2.66%	1.27%	−45.1%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	VORVOR BIOPHARMA INC	—	1.38%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	OBIOOrchestra BioMed Holdings Inc	—	1.34%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TRVITrevi Therapeutics Inc	—	1.13%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	OCULOcular Therapeutix Inc	—	1.10%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	UPBUpstream Bio Inc	—	1.01%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	EYPTEyepoint Inc.	—	0.99%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	FDMT4D Molecular Therapeutics Inc	—	0.95%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	PALIPalisade Bio Inc	—	0.88%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	ZVRAZevra Therapeutics Inc	0.45%	1.29%	+154.5%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	Zealand Pharma As	—	0.82%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	RGNXREGENXBIO Inc	0.73%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	IMUXImmunic Inc.	—	0.70%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	CHRSCoherus Oncology Inc.	—	0.62%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	KLRSKALARIS THERAPEUTICS INC	0.23%	0.73%	+335.5%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	CRVSCorvus Pharmaceuticals Inc	—	0.43%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	OVIDOvid Therapeutics Inc	—	0.42%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	LENZLENZ Therapeutics Inc	0.37%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	IVAInventiva SA	2.09%	1.82%	−32.5%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	ARTVARTIVA BIOTHERAPEUTICS INC	—	0.22%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	CONNECT BIOPHARMA HOLDINGS LTD	—	0.20%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	CLDXCelldex Therapeutics Inc.	3.07%	3.16%	−18.8%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	APLTApplied Therapeutics Inc	0.07%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	Oculis Holding AG	2.62%	2.56%	−32.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AARDAardvark Therapeutics Inc	0.05%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	SABSSab Biotherapeutics Inc	1.03%	1.03%	−10.1%	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.